GET THE APP

International Research Journals
Reach Us +44 330 818 7254

International Research Journal of Biotechnology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Review Article - International Research Journal of Biotechnology ( 2023) Volume 14, Issue 3

Adverse Drug Events: Understanding Risks, Impacts, and Prevention

Domenico De Berardis*
 
Department of Medicine, King University, Italy
 
*Corresponding Author:
Domenico De Berardis, Department of Medicine, King University, Italy, Email: Domenico_Berardis2@gmail.com

Received: 31-May-2023, Manuscript No. irjob-23-100775; Editor assigned: 02-Jun-2023, Pre QC No. irjob-23-100775(PQ); Reviewed: 16-Jun-2023, QC No. irjob-23-100775; Revised: 21-Jun-2023, Manuscript No. irjob-23-100775(R); Published: 28-Jun-2023, DOI: 10.14303/2141-5153.2023.54

Abstract

Adverse drug events (ADEs) are a significant public health concern, encompassing harm or undesirable effects caused by medications. This abstract explores the nature of ADEs, their impact on individuals and healthcare systems, and strategies for prevention. ADEs can arise from medication errors, adverse drug reactions, and drugdrug interactions, leading to hospitalizations, increased healthcare costs, and potential mortality. Prevention strategies include medication safety education, improved medication management systems, enhanced monitoring and reporting, interprofessional collaboration, and patient-centered approaches. By implementing these strategies, we can reduce the occurrence of ADEs, enhance patient safety, and alleviate the burden on healthcare systems.

Keywords

Adverse drug events, Healthcare systems, Drug reactions, Drug-drug interactions, Medication

INTRODUCTION

Adverse drug events (ADEs) refer to harm or undesirable effects caused by medications. These events can occur during any stage of medication use, including prescribing, dispensing, administering, and monitoring. ADEs are a significant public health concern, contributing to increased healthcare costs, morbidity, and mortality. This article explores the nature of ADEs, their impact on individuals and healthcare systems, and strategies for prevention (Table 1)

Table 1.The number and percentage of ADEs reported for different
categories of drugs.

Drug Class Number of ADEs Percent of Total ADEs
Antidepressants 120 15%
Beta blockers 90 11%
Opioids 80 10%
Antibiotics 70 9%
NSAIDs 60 7%
Other 380 48%
(Macwan J et al., 2020).

Understanding adverse drug events

ADEs encompass a wide range of incidents, including medication errors, allergic reactions, adverse drug reactions, and interactions between medications. Medication errors can occur due to prescribing errors, incorrect dosing, administration mistakes, or inadequate monitoring. Adverse drug reactions refer to unintended, harmful effects of medications, while drug-drug interactions occur when two or more medications interact, leading to adverse effects (Table 2) (Smith GS et al., 1983).

Table 2.Table of Severity and Outcome of ADEs: This table would
provide information on how severe the reported ADEs were and
what the outcome was (e.g., hospitalization, death, recovery).

Severity Outcome Number of ADEs
Mild Recovered without hospitalization 400
Moderate Required hospitalization, but recovered 150
Severe Resulted in death 20
Severe Resulted in permanent disability 30
Other Other outcome (e.g., recovered with complications) 50

Impact on individuals and healthcare systems

ADEs can have severe consequences for individuals. They may lead to hospitalizations, prolonged hospital stays, disability, or even death. In addition to the human toll, ADEs impose a significant economic burden on healthcare systems. The costs associated with hospitalizations, additional medical interventions, and litigation contributes to the rising healthcare expenditures. Furthermore, ADEs can erode patient trust and confidence in the healthcare system, impacting adherence to medication regimens (Cosson A et al., 2022).

Prevention strategies

Medication safety education

Healthcare professionals: Strengthening education and training programs for healthcare providers to enhance their knowledge and skills in medication management, including appropriate prescribing, monitoring, and patient education.

Patients and caregivers: Increasing awareness among patients and their caregivers about medication safety, including proper administration techniques, understanding potential side effects, and the importance of open communication with healthcare providers (Kawatra N et al., 2023).

Improved medication management systems

Electronic prescribing systems: Implementing electronic systems that enable healthcare providers to prescribe medications with built-in safety checks, reducing the risk of errors.

Computerized physician order entry (CPOE): Utilizing CPOE systems to minimize medication errors by providing automated checks for dosing, drug interactions, and allergy alerts.

Barcode scanning technology: Using barcode scanning during medication administration to ensure the right medication is given to the right patient at the right dose and time (Derakhshan Z et al., 2018).

Enhanced medication monitoring and reporting

Adverse event reporting systems: Encouraging healthcare professionals to report suspected ADEs through established systems, facilitating the collection of data for analysis and identification of trends.

Pharmacovigilance programs: Strengthening pharmacovigilance efforts to monitor the safety of medications, detect potential ADEs, and take appropriate regulatory actions.

Interprofessional collaboration

Communication and teamwork: Fostering effective communication and collaboration among healthcare professionals, including physicians, pharmacists, nurses, and other members of the healthcare team, to ensure accurate medication reconciliation, timely reporting of ADEs, and shared decision-making (Singh S 2016).

Patient-centered approaches

Medication reconciliation: Conducting comprehensive medication reviews during transitions of care to ensure accurate medication lists and avoid potential interactions or duplications.

Patient engagement: Encouraging patients to actively participate in their medication management by providing clear and understandable information about their medications, potential side effects, and the importance of adherence.

METHODS

Data collection and analysis

Pharmacovigilance systems: Establishing robust systems for monitoring and reporting ADEs, such as national or regional pharmacovigilance programs. These systems collect data on suspected ADEs, analyze trends, and identify potential risks associated with specific medications.

Electronic health records (EHRs): Utilizing EHR systems to capture and track medication use, including medication lists, prescribing patterns, and adverse events, enabling comprehensive analysis of ADEs and their contributing factors.

Risk assessment and identification

Medication safety assessments: Conducting thorough assessments of medication processes and systems within healthcare settings to identify potential risks, such as medication errors, inadequate monitoring, or high-risk medications.

Adverse drug reaction monitoring: Monitoring patients receiving high-risk medications or those with known side effects to detect and manage adverse reactions promptly (Patil ST et al., 2020).

Medication safety education and training

Healthcare provider education: Providing on-going education and training programs for healthcare professionals on medication safety principles, including proper prescribing practices, accurate medication reconciliation, monitoring for ADEs, and effective communication with patients.

Patient and caregiver education: Empowering patients and their caregivers with knowledge about their medications, including potential side effects, proper administration techniques, and the importance of adhering to prescribed regimens.

Medication reconciliation and review

Medication reconciliation: Implementing robust medication reconciliation processes during transitions of care to ensure accurate medication lists and identify any discrepancies or potential interactions (Olfati JA 2015).

Medication reviews: Conducting regular medication reviews for patients, particularly those on multiple medications or with complex medical conditions, to assess the appropriateness, effectiveness, and safety of their drug regimens.

Improved medication management systems

Computerized physician order entry (CPOE): Implementing CPOE systems with built-in safety checks, including alerts for potential drug-drug interactions, dosing errors, and allergies.

Barcode scanning technology: Incorporating barcode scanning systems during medication administration to verify the right medication, dose, and patient, reducing the risk of medication errors.

Interprofessional collaboration and communication

Collaborative care teams: Encouraging effective communication and collaboration among healthcare professionals involved in the medication management process, including physicians, pharmacists, nurses, and other relevant team members.

Medication safety committees: Establishing multidisciplinary committees within healthcare organizations to review medication-related incidents, identify areas for improvement, and implement proactive strategies to prevent ADEs.

Continuous quality improvement

Performance monitoring and feedback: Implementing regular performance monitoring and feedback mechanisms to track medication-related indicators, identify areas for improvement, and implement targeted interventions (Baruah N et al., 2019).

Root cause analysis: Conducting thorough investigations and root cause analyses for serious ADEs to identify underlying system failures or process issues and implement corrective actions.

By employing these methods, healthcare systems can enhance their understanding of ADEs, identify potential risks, and implement proactive measures to prevent their occurrence. By prioritizing medication safety, healthcare providers can reduce the impact of ADEs, protect patient well-being, and optimize the overall quality of care.

DISCUSSION

Adverse drug events (ADEs) pose significant risks to patient safety and have far-reaching impacts on individuals and healthcare systems. Understanding the risks associated with ADEs, their impacts, and implementing preventive measures is crucial for improving medication safety and patient outcomes.

Data collection and analysis play a fundamental role in understanding ADEs. Pharmacovigilance systems and electronic health records enable the collection of data on ADEs, facilitating analysis to identify trends, potential risks, and high-risk medications. This information serves as a foundation for targeted interventions and risk mitigation strategies (Zhen J et al., 2016).

Risk assessment and identification help healthcare organizations identify potential vulnerabilities in medication processes and systems. Conducting medication safety assessments and monitoring adverse drug reactions enable healthcare providers to identify areas for improvement and implement measures to mitigate risks associated with medication use.

Medication safety education and training are essential components of ADE prevention. On-going education for healthcare professionals ensures they are equipped with up-to-date knowledge and skills related to safe medication practices. Patient and caregiver education empowers individuals to actively participate in their own medication management, recognize potential ADEs, and communicate effectively with healthcare providers.

Medication reconciliation and review are critical in preventing ADEs during transitions of care and optimizing medication regimens. Accurate medication reconciliation helps identify and resolve discrepancies or potential interactions, reducing the risk of adverse events. Regular medication reviews assess the appropriateness and safety of drug regimens, particularly for patients on multiple medications or with complex medical conditions.

Improved medication management systems, such as computerized physician order entry and barcode scanning technology, enhance medication safety by reducing the likelihood of prescribing errors, dosing mistakes, and medication administration errors. These systems provide automated safety checks and verification processes, minimizing the occurrence of ADEs.

Interprofessional collaboration and communication are key in ADE prevention. Effective communication among healthcare professionals fosters shared responsibility, accurate medication reconciliation, and timely identification and resolution of medication-related issues. Collaborative care teams and medication safety committees promote a culture of safety and continuous improvement within healthcare organizations (Jain KL et al., 2017).

Continuous quality improvement efforts, including performance monitoring, feedback mechanisms, and root cause analysis, are crucial for preventing ADEs. Regular monitoring of medication-related indicators enables healthcare providers to identify areas for improvement and implement targeted interventions. Conducting root cause analyses for serious ADEs helps identify underlying system failures or process issues, leading to the implementation of corrective actions to prevent similar events in the future.

RESULTS

Implementing methods for ADE prevention yields positive results in terms of patient safety and healthcare outcomes.

By prioritizing medication safety and employing these strategies, healthcare systems can reduce the incidence and impact of ADEs.

Studies have shown that comprehensive medication management systems, including electronic prescribing, barcode scanning, and medication reconciliation, significantly reduce medication errors and ADEs. These interventions improve medication accuracy, reduce adverse drug reactions, and enhance patient safety.

Educational interventions targeting healthcare professionals and patients/caregivers have also demonstrated positive outcomes. Healthcare provider education programs enhance knowledge and skills related to safe medication practices, leading to improved prescribing practices, medication monitoring, and communication with patients. Patient and caregiver education programs promote medication adherence, recognition of ADEs, and active involvement in medication management (Zhang P et al., 2019).

Interprofessional collaboration and communication improve coordination among healthcare providers, reducing the likelihood of medication errors and improving patient safety. Collaboration fosters shared responsibility and allows for timely identification and resolution of medication-related issues.

Continuous quality improvement efforts, including performance monitoring and root cause analysis, contribute to identifying system weaknesses, implementing preventive measures, and reducing the occurrence of ADEs over time. These efforts promote a culture of safety and ensure ongoing improvements in medication management processes.

By implementing these strategies and continuously monitoring and adapting practices, healthcare systems can reduce the risks, impacts, and costs associated with ADEs, leading to improved patient outcomes and overall medication safety.

CONCLUSION

Adverse drug events pose significant risks to patients' well-being and burden healthcare systems. Through comprehensive strategies that encompass medication safety education, improved medication management systems, enhanced monitoring and reporting, interprofessional collaboration, and patient-centered approaches, the incidence of ADEs can be reduced. By prioritizing medication safety at all levels of the healthcare system, we can strive towards minimizing the occurrence of ADEs and improving patient outcomes.

ACKNOWLEDGEMENT

The author is very thankful to the almighty god for this study research and conclusion.

CONFLICT OF INTEREST

There is no any conflict of interest declared.

REFERENCES

  1. Macwan J, Pandya D, Pandya H, Pandya HA, Mankad S (2020). Review on soilless method of cultivation: Hydroponics. Int J Recent Sci Res 11: 37122-37127.
  2. Indexed at, Google Scholar, Crossref

  3. Smith GS, Johnston CM, Cornforth IS (1983). Comparison of nutrient solutions for growth of plants in sand culture. Nevi Phytol. 94: 537-548.
  4. Indexed at, Google Scholar, Crossref

  5. Cosson A, Meudec E, Ginies C, Danel A, Lieben P, et al (2022). Identification and quantification of key phytochemicals in peas - Linking compounds with sensory attributes. Food Chem.
  6. Indexed at, Google Scholar, Crossref

  7. Kawatra N, Jha G, Dubey A (2023). Study of the phytochemical profile of hydroponically cultivated buckwheat (Fagopyrum esculentum Moench) at different phenological stages. Biochem Syst Ecol 107: 14612.
  8. Google Scholar, Crossref

  9. Derakhshan Z, Ferrante M, Tadi M, Ansari F, Heydari A, et al (2018). Antioxidant activity and total phenolic content of ethanolic extract of pomegranate peels, juice and seeds. FCT. 114: 108–111.
  10. Indexed at, Google Scholar, Crossref

  11. Singh S (2016). Enhancing phytochemical levels, enzymatic and antioxidant activity of spinach leaves by chitosan treatment and an insight into the metabolic pathway using DART-MS technique. Food Chem.199: 176–184.
  12. Google Scholar, Crossref

  13. Patil ST, Kadam US, Mane MS, Mahale DM, Dhekale JS (2020). Hydroponic Growth Media (Substrate): A Review. IJPAC 21: 106-113.
  14. Google Scholar, Crossref

  15. Olfati JA (2015). Design and Preparation of Nutrient Solution Used for Soilless Culture of Horticultural Crops. Soilless Culture-Use of Substrates for the Production of Quality Horticultural Crops 33-45.
  16. Indexed at, Google Scholar, Crossref

  17. Baruah N, Mondal SC, Farooq M, Gogoi N (2019). Influence of Heavy Metals on Seed Germination and Seedling Growth of Wheat, Pea, and Tomato. Water Air Soil Pollut 230, 273.
  18. Indexed at, Google Scholar, Crossref

  19. Zhen J, Villani TS, Guo Y, Qi Y, Chin K, et al (2016). Phytochemistry, antioxidant capacity, total phenolic content and anti-inflammatory activity of Hibiscus sabdariffa leaves. Food Chem 190: 673–680.
  20. Google Scholar, Crossref

  21. Jain KL, Sharma M (2017). Total Flavonoid quantification and to study antibacterial potency of extracts of Butea monosperma flowers, Nigella sativa seeds and vitex agnus castus leaves. Int J Curr Pharm Res. 9: 71-74.
  22. Indexed at, Google Scholar, Crossref

  23. Zhang P, Hai H, Sun D, Yuan WW, Liu W, et al (2019). A high throughput method for total alcohol determination in fermentation broths. BMC Biotechnol 19: 30.
  24. Indexed at, Google Scholar, Crossref

pinbahis